HYBRID EVENT: You can participate in person at Valencia, Spain or Virtually from your home or work.
Opthalamic Drug Delivery Systems
Ophthalmic drug delivery systems encompass a range of specialized methods and technologies designed for the targeted administration of medications to the eyes. These systems play a crucial role in treating various ocular conditions by enhancing drug efficacy, improving patient compliance, and minimizing side effects.
Intraocular Injections:
Intravitreal Injections: Direct injections into the vitreous cavity of the eye, commonly used for treating conditions such as macular degeneration or diabetic retinopathy. Implantable Devices:
- Ocular Inserts: Solid devices placed in the conjunctival sac that release drugs gradually over an extended period, providing a sustained therapeutic effect.
- Drug-Eluting Contact Lenses: Contact lenses designed with materials that release drugs onto the ocular surface for controlled and prolonged drug delivery.
Challenges and Innovations:
- Tear Turnover: Addressing the dynamic nature of tear turnover is a challenge for ensuring prolonged drug retention in the eye.
- Corneal Barrier: Overcoming the corneal barrier is a focus for developing strategies that facilitate effective drug penetration into intraocular tissues.
Committee Members
Consolato M Sergi
Universities of Alberta and Ottawa, Canada
Vladlen Slepak
University of Miami Miller School of Medicine, United States
Andreas M Papas
Antares Health Products, United States
Sergey Suchkov
The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian FederationSubmit your abstract Today
Title : Medical liver biopsy: Toward a personalized approach
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Mathematical modeling the disc diffusion test: Antibacterial activity of copper-doped SnO2
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Emerging formulation and delivery applications of Vitamin E TPGS
Andreas M Papas, Antares Health Products, United States
Title : The promise of nanotechnology in personalized & precision medicine: Drug discovery & development being partnered with nanotechnologies via the revolution at the nanoscale
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through design-inspired biotech- & biopharma-driven applications and upgraded business marketing to secure the human healthcare and biosafety
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad Autónoma de Baja California, Mexico
Title : Antibody-proteases as translational tools of the next-step generation to be applied for biopharmacy-related and precision medical practice
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia